Title : ( Pro-Inflammatory Cytokine Responses of A549 Epithelial Cells to Antimicrobial Peptide Brevinin-2R )
Authors: Ahmad Asoodeh , Alireza Haghparast , reyhaneh kashef , J. Chamani ,Access to full-text not allowed by authors
Abstract
Brevinin-2R is an antimicrobial peptide which has been isolated from the skin of the frog Rana ridibunda. The purpose of the present study was to examine the cellular cytotoxicity and inflammatory effects of brevinin-2R (B2R) on human lung epithelial adenocarcinoma cell line A549. The effects of different concentrations (5, 10, and 20 lg/ml) of B2R on the expression levels of pro-inflammatory cytokines such as IL-1b, and IL-8 in A549 cells were evaluated by semi-quantitative RT-PCR and real-time PCR assays in a dose- and time-dependent manner. Based on the results of MTT assay, B2R showed a moderate cytotoxicity effect in a dose-dependent manner up to 20 % suppression of the cell growth. Moreover, gene expression results demonstrated that B2R up-regulates the IL-1b and IL-8 expression levels in A549 cells in a dose- and timedependent manner. Our results suggested that brevinin-2R antimicrobial peptide has potentially a regulatory effect on triggering the inflammatory processes.
Keywords
, Brevinin, 2R Pro, inflammatory cytokine Inflammation MTT assay Real time PCR@article{paperid:1035039,
author = {Asoodeh, Ahmad and Haghparast, Alireza and Kashef, Reyhaneh and J. Chamani},
title = {Pro-Inflammatory Cytokine Responses of A549 Epithelial Cells to Antimicrobial Peptide Brevinin-2R},
journal = {International Journal of Peptide Research and Therapeutics},
year = {2013},
volume = {19},
number = {2},
month = {June},
issn = {1573-3149},
pages = {157--162},
numpages = {5},
keywords = {Brevinin-2R Pro-inflammatory cytokine
Inflammation MTT assay Real time PCR},
}
%0 Journal Article
%T Pro-Inflammatory Cytokine Responses of A549 Epithelial Cells to Antimicrobial Peptide Brevinin-2R
%A Asoodeh, Ahmad
%A Haghparast, Alireza
%A Kashef, Reyhaneh
%A J. Chamani
%J International Journal of Peptide Research and Therapeutics
%@ 1573-3149
%D 2013